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The r i s k of hemorrhage i n ITP i s r e l a t e d not only t o t h e platel e t count but a l s o t o t h e functional i n t e g r i t y of t h e p l a t e l e t s and microvasculature. P l a t e l e t function i n a d u l t s with ITP has been reported by d i f f e r e n t i n v e s t i g a t o r s t o e i t h e r be enhanced (bleeding time (BT) s h o r t e r than expected f o r t h e degree of thrombocytopenia) o r impaired ( d e f e c t i v e aggregation due t o e f f e c t s of a n t i -p l a t e l e t antibody). These discrepant r e s u l t s a r e unexplained and d a t a i n p e d i a t r i c p a t i e n t s a r e lacking.Therefore, we investigated p l a t e l e t function i n 46 c h i l d r e n with acute ITP by modified template BT and i n 22 c h i l d r e n with chronic ITP by BT, p l a t e l e t aggregation i n response t o epinephrine, collagen and ADP, and/or generation of malondialdehyde (MDA) following exposure of p l a t e l e t s t o N-ethylmaleimide. BT, performed on 185 occasions i n t h e 68 p a t i e n t s , was nearly always prolonged ( > 7 1/2 minutes) when t h e p l a t e l e t count was under 100,00O/pl and markedly prolonged ( > 25 minutes) i n 52% of children whose p l a t e l e t counts were < 20,00O/pl. BT values i n t h e p a t i e n t s with ITP were not d i f f e r e n t from those i n 20 children with thrombocytopenia due t o decreased p l a t e l e t production. BT was not a f f e ct e d by c o r t i c o s t e r o i d therapy independent of p l a t e l e t count. P l a t e l e t aggregation and MDA measurements performed on 18 occasions i n 12 p a t i e n t s with chronic ITP were usually normal. We conclude t h a t p l a t e l e t r e a c t i v i t y i s n e i t h e r enhanced nor s i g n if i c a n t l y impaired i n childhood ITP. The lupus-like anticoagulant is being seen more frequently i n t h e p e d i a t r i c population, p a r t i c u l a r l y a s a t r a n s i e n t occurrence a f t e r a presumed v i r a l URI. W e herewith report t h e t r a n s i e n t occurrence of lupus-li ke anticoagulant in a p a t i e n t , h i s s i s t e r and h i s mother, a l l o f whom shared t h e same HLA haplotype. The p a t i e n t i s a 6-year-old white male diagnosed a s having AML i n 9/80 who went i n t o remission with CCSG-251 (combination a d r i amycin + ARA-C). The p a t i e n t was randomized t o t h e t r a n s p l a n t arm o f CCSG-251 and upon routine screening a PTT of 75 was discovered. Work-up revealed a c i r c u l a t i n g anticoagulant of the lupus-type (Rapaport, AIM 2/80) with decreased f a c t o r s IX, and XI1 and a c l e a r c u t prolongation of t h e mixed PTT. The thrombin time, PT, and fibrinogen were normal. The p a t i e n t ' s e n t i r e family was evaluated. The mother and t h e HLA-identical s i s t e r (donor) had t h e same abnormalities a s t h e p a t i e n t ; while t h e two o t h e r s i bl i n g s and t h e f a t h e r did not. Follow-up s t u d i e s within two months on t h e 3 a f f e c t e d family members reverted e n t i r e l y t o normal. The family has no h i s t o r y of autoimnune disease, bleeding, o r thromboembolic problems. Family t e s t i n g f o r VDRL, C2 o r C4 deficiency, immune con~plexes and ANA was negative. In summary we r e p o r t 3 members of a family sharing t h e A~~B w~~ haplotype a l l of whom had t h e t r a n s i e n t simultaneous occurrence of a weak lupus-like anticoagulant.
CYCLASES IN NORMAL AND LEUKEMIC LYbITHOCYTES. Car e n t i e r i , J o s e ' J. Min u e l l , Frank H. Gardner.
797 Uni:. Texas Medical Bmnc:, ~e~t z Edand I n t e r n a l Medicine, Calveston, TX. Spon. by F.C. Schmalstieg. P e r s i s t e n t l o w l e v e l of c-AMP and p e r s i s t e n t high l e v e l of cGMP i n leukemic lymphocytes suggest a modified a c t i v i t y of the cyc l a s e s which s y n t h e t i z e them. Soluble and p a r t i c u l a t e guanylate cyclase (GC) and adenylate cyclase (AC) a c t i v i t i e s were s t u d i e d i n normal B-enriched and T-enriched lymphocytes, i n lymphocytes of c h i l d r e n w i t h acute lymphocytic leukemia (ALL) and a d u l t s with chronic lymphocytic leukemia (CLL). GC a c t i v i t y was g r e a t e r i n normal T than B c e l l s (10.2 v s 5.3 pmol/min/mg p r o t e i n ) , increased l i t t l e with isoproterenol and prostaglandins stimulation,and much more with sodium a z i d e (NaN3) and dehydroascorbic acid (DHA) s t i mu l a t i o n (19 and 23 pmol f o r T c e l l s and 9.1 and 17.2 pmol f o r B c e l l s ) . GC a c t i v i t y was g r e a t e r i n both types of leukemiclymphoc y t e s (23 pmol f o r ALL c e l l s and 1 8 pmol f o r CLL c e l l s ) and was i n s e n s i t i v e t o s t i m u l a t i o n with DHA and NaN3. P a r t i c u l a t e AC act i v i t y was g r e a t e r i n normal B than T c e l l s (215 vs 80 pmol) and increased i n both a f t e r s t i m u l a t i o n with isoproterenol(300 pmol) and prostaglandins (400 pmol). I n leukemic lymphocytes AC showed depressed a c t i v i t y (20 pmol i n ALL c e l l s and 55 pmol i n CLL c e l l s ) and was i n s e n s i t i v e t o stimulation. These findings suggest t h a t c i r c u l a t i n g T c e l l s a r e more a c t i v e l y cycling o r functioningthan c i r c u l a t i n g B c e l l s . They a l s o suggest a derangement of t h e act i v i t y of both cyclases and/or t h e i r receptors i n leukemic c e l l s : thisderangement may be a cause of leukemic c e l l escape from t h e i r microenvironment c o n t r o l .
ACTIN UNDERGOES RAPID AND REVERSIBLE POLYMERIZATION
798 ASSOCIATED WITH PLATELET SHAPE CHANGE. James F.
Casella and Shin Lin. (Sponsored by William H. Zinkham). The Johns Hopkins Univ., Dept. of Biophysics, and The Johns Hopkins Hospital, Dept. of P e d i a t r i c s , Baltimore. (F) form. The present study was designed t o determine t h e polymerization s t a t e of a c t i n under conditions associated with p l a t e l e t shape change without aggregation, i n t h e presence and absence of i n h i b i t o r s of shape change. Cytochalasin D (CD) i s an agent which i n h i b i t s p l a t e l e t shape change as well a s a c t i n polymerization i n v i t r o . EDTA-treated, g e l -f i l t e r e d p l a t e l e t s were exposed t o t h e experimental conditions described below pr:lor t o T r i t o n l y s i s . G-actin was measured by t h e DNAse assay of Bliks t a d e t a l . Total c e l l u l a r a c t i n was determined by assay of lys a t e s exposed t o guanidine HC1. Results were expressed a s % of t o t a l a c t i n measurable a s G-actin k SEM a s follows: (1)unstimulated 6 7 . 5 5 . 4 , n=32, (2)thrombin-stimulated 3 6 . 8 9 . 2 , n=25, (3)CDt r e a t e d (before thrombin) 62.422.1, n=21, (4)CD-treated ( a f t e r thrombin) 69.4k2.0, n=8, (5)ADP-stimulated 44.051.0, n=4, (6)Adenosine-treated ( p r i o r t o ADP) 6 3 . e 3 . 1 , n=4, (7)CD-treated ( p r i o r t o ADP) 66.825.7, n=4. These f i n d i n g s i n d i c a t e t h a t p l a t e l e t a c t l n is r e v e r s i b l y transformed from G-actin t o F-actin during shape change. This transformation i s blocked both by a drug which comp e t i t i v e l y i n h i b i t s stimulation and shape change (adenosine), and a drug which i n h i b i t s a c t i n polymerization and shape change (CD). The hematologic hallmark of sickle cell disease is the irreversibly sickled cell (ISC) a shrunken, dehydrated cell which resists hypotonic lysis. Less well recognized in sickle cell disease is another population of cells geometrically "spher~cytic'~ with decreased surface area t o volume ratio and increased osmotic fragility. In 59 stable patients with HbSS, we determined hematologic values, ISC counts, the proportion of red cells identified by Nomarski optics as containing "pits", and the proportion of osmotically labile cells. 80% of HbSS patients had an abnormal osmotic fragility curve characterized by a "tail" of hypotonically labile cells whereas none of the normal controls lysed in solutions less hypotonic than 0.5% saline. In patients with abnormal curves, 0.55% buffered saline NHL1s of children a r e a heterogeneous group of malignancies which when disseminated respond poorly t o therapy. In CCSG 551, a stratified prospective trial for children with NHL, we randomized 314 patients t o receive 4 drugs (COMP) or 10 drugs (modified LSA L ) All patients received radiation t o bulk disease and p r o p h y l a c t i~ I%' methotrexate. Patients were grouped by extent of disease (regional vs. disseminated), and histologic type (lymphoblastic vs. non-lymphoblastic).
P l a t e l e t s undergo dramatic c y t o s k e l e t a l changes following activation. Previous s t u d i e s have suggested t h a t these changes a r e r e l a t e d t o the conversion of a c t i n from monomeric (G) t o t h e f i lamentous
Of the 6 0 patients with regional disease, 85% remained f r e e of disease a t 24 rnos,.
regardless of histology or treatment arm. Of the 254 patients with disseminated disease, 76% of those with lymphoblastic histology remained disease f r e e a t 18 months using 10 drugs while only 36% were still in 1st remission on the 4 drug protocol (p < 0.05). In contrast, 61% of those patients with non-lymphoblastic morphology remained in 1st remission a t 18 mos on 4 drugs, but only 29% were still in 1st remission using 10 drugs (p 0.05). As the overall toxicity of the 10 drug protocol exceeded that of the 4 drug protocol, we now treat all patients with regional disease with local irradiation and the 4 drug protocol. For patients with disseminated disease t h e 10 drug protocol is superior for lymphoblastic disease while the 4 drug is advantageous for other histologies.
